Michael S Urdea

USPTO Granted Patents = 63 (Patent Applications = 4)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.4

ph-index = 33

Forward Citations = 6,204(Granted Patents)

Inventors with similar research interests:

Company Filing History:

Tethys Bioscience, Inc.

Health Diagnostic Laboratory, Inc.

patents

5. 1 out of 832,680

Other

patents

Years Active: 1990-2015

Loading Chart...

63 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9034585 - Diabetes-related biomarkers and methods of use thereof (2015-05-19),

2. 8409816 - Diabetes-related biomarkers and methods of use thereof (2013-04-02),

3. 8357497 - Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets (2013-01-22),

4. 8232065 - Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets (2012-07-31),

5. 8119358 - Diabetes-related biomarkers and methods of use thereof (2012-02-21),

6. 8097425 - Multiplex protein fractionation (2012-01-17),

7. 7723050 - Diabetes-related biomarkers and methods of use thereof (2010-05-25),

8. 6472522 - Purification of oligomers using dual-end selection (2002-10-29),

9. 6300056 - HIV probes for use in solution phase sandwich hybridization assays (2001-10-09),

10. 6297370 - HCV genomic sequences for diagnostics and therapeutics (2001-10-02),

11. 6235465 - HTLV-1 probes for use in solution phase sandwich hybridization assays (2001-05-22),

12. 6232462 - Reduction of nonspecific hybridization by using novel base-pairing schemes (2001-05-15),

13. 6214583 - HCV genomic sequences for diagnostics and therapeutics (2001-04-10),

14. 6190864 - HCV genomic sequences for diagnostics and therapeutics (2001-02-20),

15. 6187538 - Differential hybridization for relative quantification of variant populations (2001-02-13),

Title: Michael S Urdea - Pioneering Innovations in Diabetes Detection

Introduction: Michael S Urdea, a prolific inventor hailing from Alamo, CA, has made significant contributions to the field of biotechnology with an impressive portfolio of 63 patents. His groundbreaking work focuses on diabetes-related biomarkers that revolutionize the early detection and screening of individuals at risk of developing Diabetes.

Latest Patents: Among his latest patents is a series of inventions concerning diabetes-related biomarkers and their applications in predicting an individual's susceptibility to Diabetes. These biomarkers not only enable the accurate assessment of diabetes risk but also facilitate the screening of large populations to identify those predisposed to the condition.

Career Highlights: Throughout his career, Michael S Urdea has lent his talents to renowned companies such as Chiron Corporation and Tethys Bioscience, Inc., where he played a pivotal role in advancing biotechnological research and development. His expertise in biomarker discovery has garnered acclaim within the industry, making him a key figure in the fight against Diabetes.

Collaborations: Michael S Urdea's innovative work has been enriched by collaborations with esteemed colleagues such as Thomas Horn and Janice A Kolberg. Together, they have contributed to the advancement of biomarker technologies, setting new standards in the field of medical diagnostics.

Conclusion: In conclusion, Michael S Urdea stands as a trailblazing inventor whose dedication to improving diabetes detection has reshaped the landscape of preventive healthcare. With a remarkable patent portfolio and a legacy of impactful collaborations, he continues to drive innovation in the realm of biotechnology, paving the way for a healthier future.

This text is generated by artificial intelligence and may not be accurate.